Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07314411 · ClinicalTrials.gov registry record · NA

Carotenoid Supplementation and Retinal Health in Healthy Adults

A NA study of Healthy, sponsored by Pacific University.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07314411: Recruiting NA study of Healthy, sponsored by Pacific University.

NCT07314411 is a NA study of Healthy that is actively recruiting participants, run by Pacific University. The registered enrollment target is 50 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT07314411, a NA study of Healthy, is actively recruiting participants, sponsored by Pacific University.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to evaluate the effect of oral dietary carotenoid supplements on various aspects of retinal health. This includes assessing its impact on macular pigment optical density (MPOD), which is a protective feature of retinal health in reducing lipofuscin (retinal waste) accumulation in the retina. Our goal is to investigate the protective role of this oral carotenoid supplement on the macular structure, measured as retinal thickness, macular blood vessel density, choriocapillaris density and ocular perfusion pressure (defined as the difference between blood pressure and eye pressure) as well as evaluating visual functions such as contrast sensitivity (the ability to perceive less bold objects ) and photostress recovery time (the minimum time for a person to read the lowest level on an eye chart after shining a light in front of the eye for several seconds). This study will also investigate the relationship between skin carotenoid level and ocular carotenoid level, using a non-invasive finger measurement. Also, we want to explore the effect of carotenoid supplementation on cognitive function in terms of working memory. Understanding how this supplementation impacts all these markers is crucial for enhancing our knowledge of the potential health benefits of carotenoids in improving dietary assessment methods. This study takes 3 visits. Participants will provide written informed consent on the first visit after reviewing the study procedures, potential risks, benefits, confidentiality measures, and their right to withdraw. Then they will undergo a comprehensive history-taking and complete a validated questionnaire to screen for sensitivity to light, as well as a diet questionnaire. Following this, participant will have non-invasive testing, requiring no eye drops or dyes. This involves measurement of contrast sensitivity (CS), photostress recovery, MPOD, blood pressure (BP), intraocular pressure (IOP), skin carotenoid level, retinal thicknes

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT other

Study Locations (1)

Oregon

  • Pacific University - Forest Grove

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-04-01
Est. Completion 2026-05
Phase NA
Pacific University

11 total trials

What NCT07314411 shows while recruiting

NCT07314411 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07314411 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT07314411 about?

NCT07314411 is a clinical study titled "Carotenoid Supplementation and Retinal Health in Healthy Adults". The purpose of this research is to evaluate the effect of oral dietary carotenoid supplements on various aspects of retinal health. This includes assessing its impact on macular pigment optical density (MPOD), which is a protective feature of retinal health in reducing lipofuscin (retinal waste) acc...

What is the current status of trial NCT07314411?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-04-01. Estimated completion is 2026-05.

What conditions does trial NCT07314411 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT07314411?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), other (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07314411?

This trial is sponsored by Pacific University, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07314411 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07314411's enrollment target sits among peer trials

50 448th of 1090 higher than 618 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

  • NCT01746836 · 50 participants · Phase 2

    Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07314411, the US trial registry maintained by the National Library of Medicine. NCT07314411 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.